Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

GenBioPro

Tracked across 3 events · 136 articles · First seen May 01, 2026 · Last active May 15, 2026

Sentiment
17
Attention
6
Events
3
Relationships
16
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
6 50
Domestic
Justice Samuel Alito of the United States — Supreme Court of the United States temporarily halted an appellate court order that blocked a United States — Food and Drug Administration rule allowing the abortion pill…
Impact: GenBioPro, a manufacturer of a generic version of mifepristone, also received temporary relief from Samuel Alito's order. The company appealed to the United States — Supreme Court of the United States, stating that the 5th Circuit's decision 'unleashed regulatory chaos' and threatened access to mifepristone nationwide.
May 04, 2026 · 6 articles
6 50
Domestic
The United States — Supreme Court of the United States has temporarily restored broad access to the abortion pill mifepristone, blocking a federal appeals court ruling that had imposed new restrictions. This order, signed by…
Impact: GenBioPro, a manufacturer of a generic version of mifepristone, also filed an emergency appeal, contributing to the United States — Supreme Court of the United States's decision to restore access.
May 04, 2026 · 52 articles
6 -50
Regulatory
A federal appeals court, the United States — United States Court of Appeals for the Third Circuit, has restricted access to Mifepristone, a widely used abortion pill, by blocking its distribution via mail. The unanimous…
Impact: GenBioPro, a generic Mifepristone manufacturer, stated that the court's decision ignores the United States — Food and Drug Administration's science and decades of safe use of the drug.
May 01, 2026 · 78 articles
NEWSDESK
Track GenBioPro live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.